2012
DOI: 10.1164/rccm.201204-0710cp
|View full text |Cite
|
Sign up to set email alerts
|

The Facilitated Values History

Abstract: Many patients who develop incapacitating illness have not expressed clear treatment preferences. Therefore, surrogate decision makers are asked to make judgments about what treatment pathway is most consistent with the patient's values. Surrogates often struggle with such decisions. The difficulty arises because answering the seemingly straightforward question, "What do you think the patient would choose?" is emotionally, cognitively, and morally complex. There is little guidance for clinicians to assist famil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
32
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 98 publications
(35 citation statements)
references
References 49 publications
1
32
0
2
Order By: Relevance
“…First, surrogates sometimes believe that decisions hinge on purely technical medical judgments, and therefore underestimate the importance of their input to personalize care decisions to the patient’s values, goals, and preferences. Second, some surrogates mistakenly make decisions based on their own values or desires for the patient rather than the patient’s values; a type of projection bias (89, 65). Several communication behaviors may help overcome these problems.…”
Section: Methodsmentioning
confidence: 99%
“…First, surrogates sometimes believe that decisions hinge on purely technical medical judgments, and therefore underestimate the importance of their input to personalize care decisions to the patient’s values, goals, and preferences. Second, some surrogates mistakenly make decisions based on their own values or desires for the patient rather than the patient’s values; a type of projection bias (89, 65). Several communication behaviors may help overcome these problems.…”
Section: Methodsmentioning
confidence: 99%
“…We identified the communication skills of interest based on literature review (10, 15, 16) and a published conceptual framework for values elicitation during end-of-life decision-making. (17) Table E1 (Supplemental Digital Content 1) in the electronic supplement defines its key terms. To ensure content validity, we circulated it among experts in surrogate decision-making and presented it to clinicians at the University of Pittsburgh Medical Center whose practice involves surrogate decision-making.…”
Section: Methodsmentioning
confidence: 99%
“…[55] From the time of admission, available prognostic information, and all indicated treatment options should be openly discussed, along with a review of prior advance care planning so that the patient's wishes are respected. For patients without an advance directive, it is reasonable to initiate a time-limited trial of full intensive care therapy, except in extreme circumstances (e.g., brain death, poor premorbid function, low probability of successful intervention, and factors listed in Table 2).…”
Section: Introductionmentioning
confidence: 99%
“…Table 4 outlines an approach that facilitates discussion of a patient's values as the basis for decision-making. [55] Putting the physician's prognostic estimate of neurological outcome together with the patient's goals and values allows for a process of shared decision-making to develop a plan of care (Figure 2). …”
Section: Introductionmentioning
confidence: 99%